Ayahuasca vs DMT
A side-by-side research comparison of Ayahuasca and DMT across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Ayahuasca | DMT |
|---|---|---|
| Full name | Ayahuasca (DMT + MAO inhibitor brew) | N,N-Dimethyltryptamine |
| Category | Psychedelics | Psychedelics |
| Status | Traditional/ceremonial; research compound | Schedule I (research compound) |
| Mechanism | The MAO-inhibiting vine (harmine and related compounds) stops the body from breaking down DMT, allowing an oral psychedelic experience that activates serotonin 5-HT2A receptors. | Activates serotonin 5-HT2A receptors, producing vivid changes in perception. When taken orally in ayahuasca, an MAO inhibitor is needed so it is not broken down too quickly. |
| Molecular weight | Mixture (no single value) | 188.27 g/mol |
| Half-life | Several hours (extended by MAO inhibition) | ~10-15 minutes |
| Bioavailability | Oral | Inhaled/injected (very short); oral only with an MAO inhibitor |
| Typical dose | Brew-based, varies by preparation | Controlled dosing in clinical studies |
| Frequency | Ceremonial or occasional study sessions | One to a few supervised sessions |
| Route | Oral brew | Inhalation or IV in research; oral as ayahuasca |
Ayahuasca reported benefits
- Studied for treatment-resistant depression
- Explored for grief and trauma
- Long history of ceremonial use
- May produce lasting shifts in outlook
DMT reported benefits
- Studied for depression
- Very short experience aids research design
- Used to study consciousness
- Long traditional use as ayahuasca
Related comparisons
Research and educational reference only. Not medical advice.